0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV-1 ELISA Kits Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-30M16610
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global HIV 1 ELISA Kits Market Research Report 2024
BUY CHAPTERS

Global HIV-1 ELISA Kits Market Research Report 2026

Code: QYRE-Auto-30M16610
Report
2026-04-16
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HIV-1 ELISA Kits Market

The global HIV-1 ELISA Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on HIV-1 ELISA Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
HIV-1 ELISA kits are enzyme-linked immunosorbent assay kits designed for the detection and quantification of antibodies specific to Human Immunodeficiency Virus type 1 (HIV-1) in biological samples. These kits use the ELISA method to detect the presence of antibodies produced by the immune system in response to HIV-1 infection. HIV-1 ELISA kits are integral in diagnosing HIV infections, monitoring disease progression, and screening blood donations for HIV. They provide a sensitive and specific tool for detecting antibodies against HIV-1, aiding in the early detection and management of the virus in clinical settings.
The industry trend for HIV-1 ELISA kits is evolving in response to the global HIV epidemic and the need for accurate diagnostic tools. With a focus on early detection and treatment of HIV infections to mitigate transmission and improve patient outcomes, there is a growing demand for reliable and high-quality ELISA kits for HIV-1. Manufacturers are constantly innovating to improve the sensitivity, specificity, and accessibility of these kits, making them essential in healthcare settings worldwide. As diagnostic testing plays a pivotal role in HIV management and prevention strategies, the market for HIV-1 ELISA kits is expected to continue growing.
This report delivers a comprehensive overview of the global HIV-1 ELISA Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HIV-1 ELISA Kits. The HIV-1 ELISA Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global HIV-1 ELISA Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist HIV-1 ELISA Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of HIV-1 ELISA Kits Market Report

Report Metric Details
Report Name HIV-1 ELISA Kits Market
Segment by Type
  • Anti-HIV-1
  • HIV-1
by Application
  • Hospital
  • Laboratory
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MyBioSource, XpressBio, R&D Systems, RayBiotech, Abbexa, Sino Biological, Novus Biologicals, Abnova Corporation, OriGene Technologies, United States Biological, Wuhan Fine Biotech, ACROBiosystems, Krishgen Biosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for HIV-1 ELISA Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines HIV-1 ELISA Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the HIV-1 ELISA Kits Market report?

Ans: The main players in the HIV-1 ELISA Kits Market are MyBioSource, XpressBio, R&D Systems, RayBiotech, Abbexa, Sino Biological, Novus Biologicals, Abnova Corporation, OriGene Technologies, United States Biological, Wuhan Fine Biotech, ACROBiosystems, Krishgen Biosystems

What are the Application segmentation covered in the HIV-1 ELISA Kits Market report?

Ans: The Applications covered in the HIV-1 ELISA Kits Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the HIV-1 ELISA Kits Market report?

Ans: The Types covered in the HIV-1 ELISA Kits Market report are Anti-HIV-1, HIV-1

1 HIV-1 ELISA Kits Market Overview
1.1 Product Definition
1.2 HIV-1 ELISA Kits by Type
1.2.1 Global HIV-1 ELISA Kits Market Value by Type: 2025 vs 2032
1.2.2 Anti-HIV-1
1.2.3 HIV-1
1.3 HIV-1 ELISA Kits by Application
1.3.1 Global HIV-1 ELISA Kits Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Global HIV-1 ELISA Kits Market Size Estimates and Forecasts
1.4.1 Global HIV-1 ELISA Kits Revenue 2021–2032
1.4.2 Global HIV-1 ELISA Kits Sales 2021–2032
1.4.3 Global HIV-1 ELISA Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 HIV-1 ELISA Kits Market Competition by Manufacturers
2.1 Global HIV-1 ELISA Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global HIV-1 ELISA Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global HIV-1 ELISA Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of HIV-1 ELISA Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of HIV-1 ELISA Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of HIV-1 ELISA Kits, Product Types and Applications
2.7 Global Key Manufacturers of HIV-1 ELISA Kits, Date of Entry into the Industry
2.8 Global HIV-1 ELISA Kits Market Competitive Situation and Trends
2.8.1 Global HIV-1 ELISA Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global HIV-1 ELISA Kits Players Market Share by Revenue
2.8.3 Global HIV-1 ELISA Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HIV-1 ELISA Kits Market Scenario by Region
3.1 Global HIV-1 ELISA Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global HIV-1 ELISA Kits Sales by Region: 2021–2032
3.2.1 Global HIV-1 ELISA Kits Sales by Region: 2021–2026
3.2.2 Global HIV-1 ELISA Kits Sales by Region: 2027–2032
3.3 Global HIV-1 ELISA Kits Revenue by Region: 2021–2032
3.3.1 Global HIV-1 ELISA Kits Revenue by Region: 2021–2026
3.3.2 Global HIV-1 ELISA Kits Revenue by Region: 2027–2032
3.4 North America HIV-1 ELISA Kits Market Facts & Figures by Country
3.4.1 North America HIV-1 ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America HIV-1 ELISA Kits Sales by Country (2021–2032)
3.4.3 North America HIV-1 ELISA Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV-1 ELISA Kits Market Facts & Figures by Country
3.5.1 Europe HIV-1 ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe HIV-1 ELISA Kits Sales by Country (2021–2032)
3.5.3 Europe HIV-1 ELISA Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV-1 ELISA Kits Market Facts & Figures by Region
3.6.1 Asia Pacific HIV-1 ELISA Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific HIV-1 ELISA Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific HIV-1 ELISA Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV-1 ELISA Kits Market Facts & Figures by Country
3.7.1 Latin America HIV-1 ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America HIV-1 ELISA Kits Sales by Country (2021–2032)
3.7.3 Latin America HIV-1 ELISA Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HIV-1 ELISA Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV-1 ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa HIV-1 ELISA Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa HIV-1 ELISA Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV-1 ELISA Kits Sales by Type (2021–2032)
4.1.1 Global HIV-1 ELISA Kits Sales by Type (2021–2026)
4.1.2 Global HIV-1 ELISA Kits Sales by Type (2027–2032)
4.1.3 Global HIV-1 ELISA Kits Sales Market Share by Type (2021–2032)
4.2 Global HIV-1 ELISA Kits Revenue by Type (2021–2032)
4.2.1 Global HIV-1 ELISA Kits Revenue by Type (2021–2026)
4.2.2 Global HIV-1 ELISA Kits Revenue by Type (2027–2032)
4.2.3 Global HIV-1 ELISA Kits Revenue Market Share by Type (2021–2032)
4.3 Global HIV-1 ELISA Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global HIV-1 ELISA Kits Sales by Application (2021–2032)
5.1.1 Global HIV-1 ELISA Kits Sales by Application (2021–2026)
5.1.2 Global HIV-1 ELISA Kits Sales by Application (2027–2032)
5.1.3 Global HIV-1 ELISA Kits Sales Market Share by Application (2021–2032)
5.2 Global HIV-1 ELISA Kits Revenue by Application (2021–2032)
5.2.1 Global HIV-1 ELISA Kits Revenue by Application (2021–2026)
5.2.2 Global HIV-1 ELISA Kits Revenue by Application (2027–2032)
5.2.3 Global HIV-1 ELISA Kits Revenue Market Share by Application (2021–2032)
5.3 Global HIV-1 ELISA Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MyBioSource
6.1.1 MyBioSource Company Information
6.1.2 MyBioSource Description and Business Overview
6.1.3 MyBioSource HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MyBioSource HIV-1 ELISA Kits Product Portfolio
6.1.5 MyBioSource Recent Developments/Updates
6.2 XpressBio
6.2.1 XpressBio Company Information
6.2.2 XpressBio Description and Business Overview
6.2.3 XpressBio HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 XpressBio HIV-1 ELISA Kits Product Portfolio
6.2.5 XpressBio Recent Developments/Updates
6.3 R&D Systems
6.3.1 R&D Systems Company Information
6.3.2 R&D Systems Description and Business Overview
6.3.3 R&D Systems HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 R&D Systems HIV-1 ELISA Kits Product Portfolio
6.3.5 R&D Systems Recent Developments/Updates
6.4 RayBiotech
6.4.1 RayBiotech Company Information
6.4.2 RayBiotech Description and Business Overview
6.4.3 RayBiotech HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 RayBiotech HIV-1 ELISA Kits Product Portfolio
6.4.5 RayBiotech Recent Developments/Updates
6.5 Abbexa
6.5.1 Abbexa Company Information
6.5.2 Abbexa Description and Business Overview
6.5.3 Abbexa HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Abbexa HIV-1 ELISA Kits Product Portfolio
6.5.5 Abbexa Recent Developments/Updates
6.6 Sino Biological
6.6.1 Sino Biological Company Information
6.6.2 Sino Biological Description and Business Overview
6.6.3 Sino Biological HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sino Biological HIV-1 ELISA Kits Product Portfolio
6.6.5 Sino Biological Recent Developments/Updates
6.7 Novus Biologicals
6.7.1 Novus Biologicals Company Information
6.7.2 Novus Biologicals Description and Business Overview
6.7.3 Novus Biologicals HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Novus Biologicals HIV-1 ELISA Kits Product Portfolio
6.7.5 Novus Biologicals Recent Developments/Updates
6.8 Abnova Corporation
6.8.1 Abnova Corporation Company Information
6.8.2 Abnova Corporation Description and Business Overview
6.8.3 Abnova Corporation HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abnova Corporation HIV-1 ELISA Kits Product Portfolio
6.8.5 Abnova Corporation Recent Developments/Updates
6.9 OriGene Technologies
6.9.1 OriGene Technologies Company Information
6.9.2 OriGene Technologies Description and Business Overview
6.9.3 OriGene Technologies HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 OriGene Technologies HIV-1 ELISA Kits Product Portfolio
6.9.5 OriGene Technologies Recent Developments/Updates
6.10 United States Biological
6.10.1 United States Biological Company Information
6.10.2 United States Biological Description and Business Overview
6.10.3 United States Biological HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 United States Biological HIV-1 ELISA Kits Product Portfolio
6.10.5 United States Biological Recent Developments/Updates
6.11 Wuhan Fine Biotech
6.11.1 Wuhan Fine Biotech Company Information
6.11.2 Wuhan Fine Biotech Description and Business Overview
6.11.3 Wuhan Fine Biotech HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wuhan Fine Biotech HIV-1 ELISA Kits Product Portfolio
6.11.5 Wuhan Fine Biotech Recent Developments/Updates
6.12 ACROBiosystems
6.12.1 ACROBiosystems Company Information
6.12.2 ACROBiosystems Description and Business Overview
6.12.3 ACROBiosystems HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ACROBiosystems HIV-1 ELISA Kits Product Portfolio
6.12.5 ACROBiosystems Recent Developments/Updates
6.13 Krishgen Biosystems
6.13.1 Krishgen Biosystems Company Information
6.13.2 Krishgen Biosystems Description and Business Overview
6.13.3 Krishgen Biosystems HIV-1 ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Krishgen Biosystems HIV-1 ELISA Kits Product Portfolio
6.13.5 Krishgen Biosystems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV-1 ELISA Kits Industry Chain Analysis
7.2 HIV-1 ELISA Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV-1 ELISA Kits Production Mode & Process Analysis
7.4 HIV-1 ELISA Kits Sales and Marketing
7.4.1 HIV-1 ELISA Kits Sales Channels
7.4.2 HIV-1 ELISA Kits Distributors
7.5 HIV-1 ELISA Kits Customer Analysis
8 HIV-1 ELISA Kits Market Dynamics
8.1 HIV-1 ELISA Kits Industry Trends
8.2 HIV-1 ELISA Kits Market Drivers
8.3 HIV-1 ELISA Kits Market Challenges
8.4 HIV-1 ELISA Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global HIV-1 ELISA Kits Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global HIV-1 ELISA Kits Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global HIV-1 ELISA Kits Market Competitive Situation by Manufacturers in 2025
 Table 4. Global HIV-1 ELISA Kits Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global HIV-1 ELISA Kits Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global HIV-1 ELISA Kits Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global HIV-1 ELISA Kits Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market HIV-1 ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of HIV-1 ELISA Kits, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of HIV-1 ELISA Kits, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of HIV-1 ELISA Kits, Product Types and Applications
 Table 12. Global Key Manufacturers of HIV-1 ELISA Kits, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HIV-1 ELISA Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on HIV-1 ELISA Kits Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HIV-1 ELISA Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global HIV-1 ELISA Kits Sales by Region (K Units), 2021–2026
 Table 18. Global HIV-1 ELISA Kits Sales Market Share by Region (2021–2026)
 Table 19. Global HIV-1 ELISA Kits Sales by Region (K Units), 2027–2032
 Table 20. Global HIV-1 ELISA Kits Sales Market Share by Region (2027–2032)
 Table 21. Global HIV-1 ELISA Kits Revenue by Region (US$ Million), 2021–2026
 Table 22. Global HIV-1 ELISA Kits Revenue Market Share by Region (2021–2026)
 Table 23. Global HIV-1 ELISA Kits Revenue by Region (US$ Million), 2027–2032
 Table 24. Global HIV-1 ELISA Kits Revenue Market Share by Region (2027–2032)
 Table 25. North America HIV-1 ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America HIV-1 ELISA Kits Sales by Country (K Units), 2021–2026
 Table 27. North America HIV-1 ELISA Kits Sales by Country (K Units), 2027–2032
 Table 28. North America HIV-1 ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 29. North America HIV-1 ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe HIV-1 ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe HIV-1 ELISA Kits Sales by Country (K Units), 2021–2026
 Table 32. Europe HIV-1 ELISA Kits Sales by Country (K Units), 2027–2032
 Table 33. Europe HIV-1 ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe HIV-1 ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific HIV-1 ELISA Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific HIV-1 ELISA Kits Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific HIV-1 ELISA Kits Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific HIV-1 ELISA Kits Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific HIV-1 ELISA Kits Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America HIV-1 ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America HIV-1 ELISA Kits Sales by Country (K Units), 2021–2026
 Table 42. Latin America HIV-1 ELISA Kits Sales by Country (K Units), 2027–2032
 Table 43. Latin America HIV-1 ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America HIV-1 ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa HIV-1 ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa HIV-1 ELISA Kits Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa HIV-1 ELISA Kits Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa HIV-1 ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa HIV-1 ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 50. Global HIV-1 ELISA Kits Sales (K Units) by Type (2021–2026)
 Table 51. Global HIV-1 ELISA Kits Sales (K Units) by Type (2027–2032)
 Table 52. Global HIV-1 ELISA Kits Sales Market Share by Type (2021–2026)
 Table 53. Global HIV-1 ELISA Kits Sales Market Share by Type (2027–2032)
 Table 54. Global HIV-1 ELISA Kits Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global HIV-1 ELISA Kits Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global HIV-1 ELISA Kits Revenue Market Share by Type (2021–2026)
 Table 57. Global HIV-1 ELISA Kits Revenue Market Share by Type (2027–2032)
 Table 58. Global HIV-1 ELISA Kits Price (US$/Unit) by Type (2021–2026)
 Table 59. Global HIV-1 ELISA Kits Price (US$/Unit) by Type (2027–2032)
 Table 60. Global HIV-1 ELISA Kits Sales (K Units) by Application (2021–2026)
 Table 61. Global HIV-1 ELISA Kits Sales (K Units) by Application (2027–2032)
 Table 62. Global HIV-1 ELISA Kits Sales Market Share by Application (2021–2026)
 Table 63. Global HIV-1 ELISA Kits Sales Market Share by Application (2027–2032)
 Table 64. Global HIV-1 ELISA Kits Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global HIV-1 ELISA Kits Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global HIV-1 ELISA Kits Revenue Market Share by Application (2021–2026)
 Table 67. Global HIV-1 ELISA Kits Revenue Market Share by Application (2027–2032)
 Table 68. Global HIV-1 ELISA Kits Price (US$/Unit) by Application (2021–2026)
 Table 69. Global HIV-1 ELISA Kits Price (US$/Unit) by Application (2027–2032)
 Table 70. MyBioSource Company Information
 Table 71. MyBioSource Description and Business Overview
 Table 72. MyBioSource HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. MyBioSource HIV-1 ELISA Kits Product
 Table 74. MyBioSource Recent Developments/Updates
 Table 75. XpressBio Company Information
 Table 76. XpressBio Description and Business Overview
 Table 77. XpressBio HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. XpressBio HIV-1 ELISA Kits Product
 Table 79. XpressBio Recent Developments/Updates
 Table 80. R&D Systems Company Information
 Table 81. R&D Systems Description and Business Overview
 Table 82. R&D Systems HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. R&D Systems HIV-1 ELISA Kits Product
 Table 84. R&D Systems Recent Developments/Updates
 Table 85. RayBiotech Company Information
 Table 86. RayBiotech Description and Business Overview
 Table 87. RayBiotech HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. RayBiotech HIV-1 ELISA Kits Product
 Table 89. RayBiotech Recent Developments/Updates
 Table 90. Abbexa Company Information
 Table 91. Abbexa Description and Business Overview
 Table 92. Abbexa HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Abbexa HIV-1 ELISA Kits Product
 Table 94. Abbexa Recent Developments/Updates
 Table 95. Sino Biological Company Information
 Table 96. Sino Biological Description and Business Overview
 Table 97. Sino Biological HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Sino Biological HIV-1 ELISA Kits Product
 Table 99. Sino Biological Recent Developments/Updates
 Table 100. Novus Biologicals Company Information
 Table 101. Novus Biologicals Description and Business Overview
 Table 102. Novus Biologicals HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Novus Biologicals HIV-1 ELISA Kits Product
 Table 104. Novus Biologicals Recent Developments/Updates
 Table 105. Abnova Corporation Company Information
 Table 106. Abnova Corporation Description and Business Overview
 Table 107. Abnova Corporation HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Abnova Corporation HIV-1 ELISA Kits Product
 Table 109. Abnova Corporation Recent Developments/Updates
 Table 110. OriGene Technologies Company Information
 Table 111. OriGene Technologies Description and Business Overview
 Table 112. OriGene Technologies HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. OriGene Technologies HIV-1 ELISA Kits Product
 Table 114. OriGene Technologies Recent Developments/Updates
 Table 115. United States Biological Company Information
 Table 116. United States Biological Description and Business Overview
 Table 117. United States Biological HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. United States Biological HIV-1 ELISA Kits Product
 Table 119. United States Biological Recent Developments/Updates
 Table 120. Wuhan Fine Biotech Company Information
 Table 121. Wuhan Fine Biotech Description and Business Overview
 Table 122. Wuhan Fine Biotech HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Wuhan Fine Biotech HIV-1 ELISA Kits Product
 Table 124. Wuhan Fine Biotech Recent Developments/Updates
 Table 125. ACROBiosystems Company Information
 Table 126. ACROBiosystems Description and Business Overview
 Table 127. ACROBiosystems HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. ACROBiosystems HIV-1 ELISA Kits Product
 Table 129. ACROBiosystems Recent Developments/Updates
 Table 130. Krishgen Biosystems Company Information
 Table 131. Krishgen Biosystems Description and Business Overview
 Table 132. Krishgen Biosystems HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Krishgen Biosystems HIV-1 ELISA Kits Product
 Table 134. Krishgen Biosystems Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. HIV-1 ELISA Kits Distributors List
 Table 138. HIV-1 ELISA Kits Customers List
 Table 139. HIV-1 ELISA Kits Market Trends
 Table 140. HIV-1 ELISA Kits Market Drivers
 Table 141. HIV-1 ELISA Kits Market Challenges
 Table 142. HIV-1 ELISA Kits Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HIV-1 ELISA Kits
 Figure 2. Global HIV-1 ELISA Kits Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global HIV-1 ELISA Kits Market Share by Type: 2025 & 2032
 Figure 4. Anti-HIV-1 Product Picture
 Figure 5. HIV-1 Product Picture
 Figure 6. Global HIV-1 ELISA Kits Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global HIV-1 ELISA Kits Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Laboratory
 Figure 10. Others
 Figure 11. Global HIV-1 ELISA Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global HIV-1 ELISA Kits Market Size (US$ Million), 2021–2032
 Figure 13. Global HIV-1 ELISA Kits Sales (K Units), 2021–2032
 Figure 14. Global HIV-1 ELISA Kits Average Price (US$/Unit), 2021–2032
 Figure 15. HIV-1 ELISA Kits Report Years Considered
 Figure 16. HIV-1 ELISA Kits Sales Share by Manufacturers in 2025
 Figure 17. Global HIV-1 ELISA Kits Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global HIV-1 ELISA Kits Players: Market Share by Revenue in HIV-1 ELISA Kits in 2025
 Figure 19. HIV-1 ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global HIV-1 ELISA Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America HIV-1 ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 22. North America HIV-1 ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 23. United States HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe HIV-1 ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 26. Europe HIV-1 ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 27. Germany HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific HIV-1 ELISA Kits Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific HIV-1 ELISA Kits Revenue Market Share by Region (2021–2032)
 Figure 34. China HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America HIV-1 ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 42. Latin America HIV-1 ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa HIV-1 ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa HIV-1 ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE HIV-1 ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of HIV-1 ELISA Kits by Type (2021–2032)
 Figure 53. Global Revenue Market Share of HIV-1 ELISA Kits by Type (2021–2032)
 Figure 54. Global HIV-1 ELISA Kits Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of HIV-1 ELISA Kits by Application (2021–2032)
 Figure 56. Global Revenue Market Share of HIV-1 ELISA Kits by Application (2021–2032)
 Figure 57. Global HIV-1 ELISA Kits Price (US$/Unit) by Application (2021–2032)
 Figure 58. HIV-1 ELISA Kits Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String